These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 23195534)
1. Calcium depletion-mediated protease inhibition and apical-junctional-complex disassembly via an EGTA-conjugated carrier for oral insulin delivery. Chuang EY; Lin KJ; Su FY; Chen HL; Maiti B; Ho YC; Yen TC; Panda N; Sung HW J Control Release; 2013 Aug; 169(3):296-305. PubMed ID: 23195534 [TBL] [Abstract][Full Text] [Related]
2. Noninvasive imaging oral absorption of insulin delivered by nanoparticles and its stimulated glucose utilization in controlling postprandial hyperglycemia during OGTT in diabetic rats. Chuang EY; Lin KJ; Su FY; Mi FL; Maiti B; Chen CT; Wey SP; Yen TC; Juang JH; Sung HW J Control Release; 2013 Dec; 172(2):513-22. PubMed ID: 23702234 [TBL] [Abstract][Full Text] [Related]
3. Protease inhibition and absorption enhancement by functional nanoparticles for effective oral insulin delivery. Su FY; Lin KJ; Sonaje K; Wey SP; Yen TC; Ho YC; Panda N; Chuang EY; Maiti B; Sung HW Biomaterials; 2012 Mar; 33(9):2801-11. PubMed ID: 22243802 [TBL] [Abstract][Full Text] [Related]
4. Combination therapy via oral co-administration of insulin- and exendin-4-loaded nanoparticles to treat type 2 diabetic rats undergoing OGTT. Chuang EY; Nguyen GT; Su FY; Lin KJ; Chen CT; Mi FL; Yen TC; Juang JH; Sung HW Biomaterials; 2013 Oct; 34(32):7994-8001. PubMed ID: 23891516 [TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery. Lin YH; Mi FL; Chen CT; Chang WC; Peng SF; Liang HF; Sung HW Biomacromolecules; 2007 Jan; 8(1):146-52. PubMed ID: 17206800 [TBL] [Abstract][Full Text] [Related]
6. Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery. Makhlof A; Tozuka Y; Takeuchi H Eur J Pharm Sci; 2011 Apr; 42(5):445-51. PubMed ID: 21182939 [TBL] [Abstract][Full Text] [Related]
7. Intestinal mucosa permeability following oral insulin delivery using core shell corona nanolipoparticles. Li X; Guo S; Zhu C; Zhu Q; Gan Y; Rantanen J; Rahbek UL; Hovgaard L; Yang M Biomaterials; 2013 Dec; 34(37):9678-87. PubMed ID: 24016855 [TBL] [Abstract][Full Text] [Related]
8. Polyglutamic Acid Functionalization of Chitosan Nanoparticles Enhances the Therapeutic Efficacy of Insulin Following Oral Administration. Urimi D; Agrawal AK; Kushwah V; Jain S AAPS PharmSciTech; 2019 Feb; 20(3):131. PubMed ID: 30815757 [TBL] [Abstract][Full Text] [Related]
9. Multi-ion-crosslinked nanoparticles with pH-responsive characteristics for oral delivery of protein drugs. Lin YH; Sonaje K; Lin KM; Juang JH; Mi FL; Yang HW; Sung HW J Control Release; 2008 Dec; 132(2):141-9. PubMed ID: 18817821 [TBL] [Abstract][Full Text] [Related]
11. Modified nanoparticles with cell-penetrating peptide and amphipathic chitosan derivative for enhanced oral colon absorption of insulin: preparation and evaluation. Guo F; Zhang M; Gao Y; Zhu S; Chen S; Liu W; Zhong H; Liu J Drug Deliv; 2016 Jul; 23(6):2003-14. PubMed ID: 26181840 [TBL] [Abstract][Full Text] [Related]
12. Cyclodextrin complexed insulin encapsulated hydrogel microparticles: An oral delivery system for insulin. Sajeesh S; Bouchemal K; Marsaud V; Vauthier C; Sharma CP J Control Release; 2010 Nov; 147(3):377-84. PubMed ID: 20727924 [TBL] [Abstract][Full Text] [Related]
13. Thiolated Eudragit nanoparticles for oral insulin delivery: preparation, characterization and in vivo evaluation. Zhang Y; Wu X; Meng L; Zhang Y; Ai R; Qi N; He H; Xu H; Tang X Int J Pharm; 2012 Oct; 436(1-2):341-50. PubMed ID: 22766443 [TBL] [Abstract][Full Text] [Related]
14. In vitro uptake evaluation in Caco-2 cells and in vivo results in diabetic rats of insulin-loaded PLGA nanoparticles. Reix N; Parat A; Seyfritz E; Van der Werf R; Epure V; Ebel N; Danicher L; Marchioni E; Jeandidier N; Pinget M; Frère Y; Sigrist S Int J Pharm; 2012 Nov; 437(1-2):213-20. PubMed ID: 22940208 [TBL] [Abstract][Full Text] [Related]
15. Folate-decorated PLGA nanoparticles as a rationally designed vehicle for the oral delivery of insulin. Jain S; Rathi VV; Jain AK; Das M; Godugu C Nanomedicine (Lond); 2012 Sep; 7(9):1311-37. PubMed ID: 22583576 [TBL] [Abstract][Full Text] [Related]
16. Facilitated nanoscale delivery of insulin across intestinal membrane models. Woitiski CB; Sarmento B; Carvalho RA; Neufeld RJ; Veiga F Int J Pharm; 2011 Jun; 412(1-2):123-31. PubMed ID: 21501675 [TBL] [Abstract][Full Text] [Related]
17. pH-responsive nanoparticles shelled with chitosan for oral delivery of insulin: from mechanism to therapeutic applications. Sung HW; Sonaje K; Liao ZX; Hsu LW; Chuang EY Acc Chem Res; 2012 Apr; 45(4):619-29. PubMed ID: 22236133 [TBL] [Abstract][Full Text] [Related]
18. Efficient mucus permeation and tight junction opening by dissociable "mucus-inert" agent coated trimethyl chitosan nanoparticles for oral insulin delivery. Liu M; Zhang J; Zhu X; Shan W; Li L; Zhong J; Zhang Z; Huang Y J Control Release; 2016 Jan; 222():67-77. PubMed ID: 26686663 [TBL] [Abstract][Full Text] [Related]
19. Oral delivery of peptide drugs using nanoparticles self-assembled by poly(gamma-glutamic acid) and a chitosan derivative functionalized by trimethylation. Mi FL; Wu YY; Lin YH; Sonaje K; Ho YC; Chen CT; Juang JH; Sung HW Bioconjug Chem; 2008 Jun; 19(6):1248-55. PubMed ID: 18517235 [TBL] [Abstract][Full Text] [Related]
20. Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin. Zhang Y; Wei W; Lv P; Wang L; Ma G Eur J Pharm Biopharm; 2011 Jan; 77(1):11-9. PubMed ID: 20933083 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]